Peptide microarrays for the profiling of cytotoxic T-lymphocyte activity using minimum numbers of cells

Cancer Immunology, Immunotherapy

Volumn 59, Issue 9, 2010, Pages 1379-1387

  Hoff, Antje ^a,e   Bagû, Ana Cristina ^b   André, Thomas ^a,f   Roth, Günter ^a,g   Wiesmüller, Karl Heinz ^c   Gückel, Brigitte ^b   Brock, Roland ^a,d  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c EMC MICROCOLLECTIONS GMBH   (Germany)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e TRINITY COLLEGE DUBLIN   (Ireland)

^f Bachem Holding AG   (Switzerland)

^g UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cancer immunotherapy; Cellular immunity; Epitope identification; Microarrays; Microscopy

Indexed keywords

CALCEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MUCIN 1;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CELL ADHESION; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; EPITOPE MAPPING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN MICROARRAY;

CELL COUNT; CELL LINE, TUMOR; CYTOTOXICITY TESTS, IMMUNOLOGIC; EPITOPE MAPPING; FLUORESCEINS; FLUORESCENT DYES; HLA-A ANTIGENS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MICROARRAY ANALYSIS; MINIATURIZATION; MUCIN-1; NEOPLASMS; PEPTIDE FRAGMENTS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 77955512026     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-010-0867-4     Document Type: Article

References (36)

1. PG Coulie P van der Bruggen 2003 T-cell responses of vaccinated cancer patients Curr Opin Immunol 15 131 137 10.1016/S0952-7915(03)00009-8 1:CAS:528:DC%2BD3sXhvFaiu78%3D 12633661 (Pubitemid 36287517)
2. C Gouttefangeas A Stenzl S Stevanovic, et al. 2007 Immunotherapy of renal cell carcinoma Cancer Immunol Immunother 56 117 128 10.1007/s00262-006-0172-4 1:CAS:528:DC%2BD28Xht1elsb3F 16676181 (Pubitemid 44812454)
3. PJ Tacken IJ de Vries R Torensma, et al. 2007 Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting Nat Rev Immunol 7 790 802 10.1038/nri2173 1:CAS:528:DC%2BD2sXhtVOrtbjL 17853902 (Pubitemid 47480309)
4. PK Srivastava 2006 Therapeutic cancer vaccines Curr Opin Immunol 18 201 205 10.1016/j.coi.2006.01.009 1:CAS:528:DC%2BD28XitVaksb4%3D 16464565 (Pubitemid 43327303)
5. U Keilholz P Martus C Scheibenbogen 2006 Immune monitoring of T-cell responses in cancer vaccine development Clin Cancer Res 12 2346s 2352s 10.1158/1078-0432.CCR-05-2540 1:CAS:528:DC%2BD28XjtlChsbs%3D 16609057
6. C Czerkinsky G Andersson HP Ekre, et al. 1988 Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon- secreting cells J Immunol Methods 110 29 36 10.1016/0022-1759(88)90079-8 1:CAS:528:DyaL1cXkt1WhtL4%3D 3131436
7. T Jung U Schauer C Heusser, et al. 1993 Detection of intracellular cytokines by flow cytometry J Immunol Methods 159 197 207 10.1016/0022-1759(93) 90158-4 1:CAS:528:DyaK3sXktVKlurY%3D 8445253 (Pubitemid 223036072)
8. US Kammula FM Marincola SA Rosenberg 2000 Real-time quantitative polymerase chain reaction assessment of immune reactivity in melanoma patients after tumor peptide vaccination J Natl Cancer Inst 92 1336 1344 10.1093/jnci/92.16.1336 1:STN:280:DC%2BD3cvjvVCksQ%3D%3D 10944556
9. CM Britten C Gouttefangeas MJ Welters, et al. 2008 The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays Cancer Immunol Immunother 57 289 302 10.1007/s00262-007-0378-0 1:STN:280:DC%2BD2sjltlyrsg%3D%3D 17721783 (Pubitemid 350295380)
10. Y Soen DS Chen DL Kraft, et al. 2003 Detection and characterization of cellular immune responses using peptide-MHC microarrays PLoS Biol 1 e65 10.1371/journal.pbio.0000065 14691537 (Pubitemid 39112141)
11. DS Chen Y Soen TB Stuge, et al. 2005 Marked differences in human melanoma antigen-specific T cell responsiveness after vaccination using a functional microarray PLoS Med 2 e265 10.1371/journal.pmed.0020265 16162034 (Pubitemid 41554079)
12. JD Stone WE Demkowicz Jr LJ Stern 2005 HLA-restricted epitope identification and detection of functional T cell responses by using MHC-peptide and costimulatory microarrays Proc Natl Acad Sci USA 102 3744 3749 10.1073/pnas.0407019102 1:CAS:528:DC%2BD2MXisVOgtr8%3D 15728728 (Pubitemid 40354682)
13. MM Roden KH Lee MC Panelli, et al. 1999 A novel cytolysis assay using fluorescent labeling and quantitative fluorescent scanning technology J Immunol Methods 226 29 41 10.1016/S0022-1759(99)00039-3 1:CAS:528:DyaK1MXjt1Kms7k%3D 10410969 (Pubitemid 29336528)
14. KY Tsang C Palena J Yokokawa, et al. 2005 Analyses of recombinant vaccinia and fowlpox vaccine vectors expressing transgenes for two human tumor antigens and three human costimulatory molecules Clin Cancer Res 11 1597 1607 10.1158/1078-0432.CCR-04-1609 1:CAS:528:DC%2BD2MXhvVSrtrY%3D 15746065 (Pubitemid 40315245)
15. TE Carey T Takahashi LA Resnick, et al. 1976 Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells Proc Natl Acad Sci USA 73 3278 3282 10.1073/pnas.73.9.3278 1:STN:280:DyaE2s%2FhtlGhtw%3D%3D 1067619
16. A Solache CL Morgan AI Dodi, et al. 1999 Identification of three HLA-A0201-restricted cytotoxic T cell epitopes in the cytomegalovirus protein pp65 that are conserved between eight strains of the virus J Immunol 163 5512 5518 1:CAS:528:DyaK1MXntlKrtbk%3D 10553078
17. M Schirle W Keilholz B Weber, et al. 2000 Identification of tumor-associated MHC class I ligands by a novel T cell-independent approach Eur J Immunol 30 2216 2225 10.1002/1521-4141(2000)30:8<2216::AID-IMMU2216>3.0. CO;2-7 1:CAS:528:DC%2BD3cXlvFenurk%3D 10940913 (Pubitemid 30655761)
18. P Brossart KS Heinrich G Stuhler, et al. 1999 Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies Blood 93 4309 4317 1:CAS:528: DyaK1MXjvVGrtLs%3D 10361129
19. N Inzkirweli B Guckel C Sohn, et al. 2007 Antigen loading of dendritic cells with apoptotic tumor cell-preparations is superior to that using necrotic cells or tumor lysates Anticancer Res 27 2121 2129 1:CAS:528: DC%2BD2sXpvFCitLg%3D 17695495
20. JL Schultze S Michalak MJ Seamon, et al. 1997 CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy J Clin Invest 100 2757 2765 10.1172/JCI119822 1:CAS:528:DyaK2sXotVaqtbg%3D 9389740
21. S Walter L Herrgen O Schoor, et al. 2003 Cutting edge: predetermined avidity of human CD8 T cells expanded on calibrated MHC/anti-CD28-coated microspheres J Immunol 171 4974 4978 1:CAS:528:DC%2BD3sXoslyjsb8%3D 14607891
22. JD Altman PA Moss PJ Goulder, et al. 1996 Phenotypic analysis of antigen-specific T lymphocytes Science 274 94 96 10.1126/science.274.5284.94 1:CAS:528:DyaK28XmtVyns7k%3D 8810254 (Pubitemid 26332731)
23. A Hoff T André R Fischer, et al. 2004 Chemolabile cellular microarrays for the screening of small compounds and peptides Mol Divers 8 311 320 10.1023/B:MODI.0000036241.85469.85 1:CAS:528:DC%2BD2cXmtVGgsLc%3D 15384424 (Pubitemid 39061579)
24. CC Wang RP Huang M Sommer, et al. 2002 Array-based multiplexed screening and quantitation of human cytokines and chemokines J Proteome Res 1 337 343 10.1021/pr0255203 1:CAS:528:DC%2BD38Xks1aqtL8%3D 12645889 (Pubitemid 36395874)
25. V Apostolopoulos GA Pietersz IF McKenzie 1999 MUC1 and breast cancer Curr Opin Mol Ther 1 98 103 1:CAS:528:DyaK1MXhvVOrtLw%3D 11249691
26. H Hara MH Lee H Chen, et al. 1994 Role of gene expression and protein synthesis of tyrosinase, TRP-1, lamp-1, and CD63 in UVB-induced melanogenesis in human melanomas J Invest Dermatol 102 495 500 10.1111/1523-1747.ep12373136 1:CAS:528:DyaK2cXkslOgtL8%3D 8151127
27. SN Bailey DM Sabatini BR Stockwell 2004 Microarrays of small molecules embedded in biodegradable polymers for use in mammalian cell-based screens Proc Natl Acad Sci USA 101 16144 16149 10.1073/pnas.0404425101 1:CAS:528: DC%2BD2cXhtVWks7vP 15534212 (Pubitemid 39552813)
28. J Ziauddin DM Sabatini 2001 Microarrays of cells expressing defined cDNAs Nature 411 107 110 10.1038/35075114 1:STN:280:DC%2BD3M3jvFGgsg%3D%3D 11333987 (Pubitemid 32428199)
29. G Jung AG Beck-Sickinger 1992 Multiple peptide synthesis methods and their applications Angew Chemie Intl Ed 31 367 383 10.1002/anie.199203673
30. V Appay DF Nixon SM Donahoe, et al. 2000 HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function J Exp Med 192 63 75 10.1084/jem.192.1.63 1:CAS:528:DC%2BD3cXkslaitLY%3D 10880527 (Pubitemid 30470807)
31. R Mortarini A Piris A Maurichi, et al. 2003 Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma Cancer Res 63 2535 2545 1:CAS:528:DC%2BD3sXjslehtrw%3D 12750277
32. I Zehbe AM Kaufmann M Schmidt, et al. 2007 Human papillomavirus 16 E6-specific CD45RA+ CCR7+ high avidity CD8+ T cells fail to control tumor growth despite interferon-gamma production in patients with cervical cancer J Immunother 30 523 532 10.1097/CJI.0b013e31803240fa 1:CAS:528: DC%2BD2sXmslygu7s%3D 17589293 (Pubitemid 46988086)
33. S Stevanovic 2005 Antigen processing is predictable: from genes to T cell epitopes Transpl Immunol 14 171 174 10.1016/j.trim.2005.03.018 1:CAS:528:DC%2BD2MXlvVWmt7w%3D 15982559 (Pubitemid 40848522)
34. HG Rammensee T Weinschenk C Gouttefangeas, et al. 2002 Towards patient-specific tumor antigen selection for vaccination Immunol Rev 188 164 176 10.1034/j.1600-065X.2002.18815.x 1:CAS:528:DC%2BD38Xps1Oqs7w%3D 12445290 (Pubitemid 35398874)
35. R Basu S Roy P Walden 2007 HLA class I-restricted T cell epitopes of the kinetoplastid membrane protein-11 presented by Leishmania donovani-infected human macrophages J Infect Dis 195 1373 1380 10.1086/513439 1:CAS:528: DC%2BD2sXlsVOjsbc%3D 17397010 (Pubitemid 46649626)
36. Y Horiguchi I Nukaya K Okazawa, et al. 2002 Screening of HLA-A24-restricted epitope peptides from prostate-specific membrane antigen that induce specific antitumor cytotoxic T lymphocytes Clin Cancer Res 8 3885 3892 1:CAS:528:DC%2BD38XpslCjtb8%3D 12473604